Key Account Director

KEY ACCOUNT MANAGER/DIRECTOR Group Purchasing Organizations, Health System & Institutional Accounts Location: Dallas-Fort Worth, Texas and/or Philadelphia Area, PA (Preferred) U.S. Commercial Organization | National Role Rosemont Pharmaceuticals Role Focus GPO contracting and pull-through efforts, Institutional access, health-system contracting, outpatient pharmacy partnerships and neurology account development Reporting Line U.S. Commercial / Market Access Leadership Travel Approximately 50-70% national travel About Rosemont Pharmaceuticals Rosemont Pharmaceuticals is a specialty pharmaceutical company built around a differentiated focus on oral liquid medicines for patients who need alternatives to conventional solid oral dosage forms. In the United States, Rosemont is building a neurology platform led by ONTRALFY® (tizanidine oral solution), an FDA-approved oral solution indicated for the treatment of spasticity in adults. Rosemont's commercial strategy is to partner with the institutions that manage complex neurological patients and influence medication access, pharmacy fulfillment and continuity of care. Position Summary The Key Account Manager/Director , GPOs, Health System & Institutional Accounts is responsible for establishing, negotiating, executing and implementing strategic commercial agreements with large academic health systems, Integrated Delivery Networks (IDNs), 340B Covered Entities, disproportionate share hospitals (DSH), rehabilitation hospitals, Veterans Affairs and government-affiliated facilities, and health-system outpatient and specialty pharmacies. This role will create institutional access for Rosemont's current and future oral liquid medicines by building senior-level relationships with pharmacy, contracting, supply chain, neurology, physical medicine and rehabilitation (PM&R), outpatient pharmacy and executive stakeholders. The position is designed for a commercially strong account Manager/Director who can turn large health-system opportunities into executed agreements, operational implementation and measurable pull-through. Why This Role Matters Patients with neurological disorders often move through multiple sites of care: academic neurology, acute care, rehabilitation, outpatient clinics, specialty pharmacy, discharge pharmacy and home care. Many also face dysphagia, enteral feeding, caregiver administration or other medication-administration challenges. Rosemont needs a dedicated institutional account leader to connect its oral liquid portfolio with the health systems and pharmacy programs that serve these patients at scale. Primary Responsibilities Strategic account development: Identify, prioritize and manage high-value institutional accounts, including academic medical centers, IDNs, neuroscience institutes, rehabilitation hospitals, VA facilities, 340B Covered Entities and DSH hospitals. Commercial agreements: Lead development, negotiation, execution and implementation of health-system purchase agreements, institutional pharmacy agreements, outpatient pharmacy participation agreements, contract pricing arrangements, 340B-related strategies and strategic commercial partnerships. Outpatient pharmacy strategy: Build relationships with health-system outpatient pharmacies, hospital-owned specialty pharmacies, discharge pharmacies, contract pharmacies and pharmacy networks to support product availability, stocking, fulfillment and patient access. Neurology account engagement: Partner with neurology, PM&R, spasticity clinics, movement disorder programs, MS centers, stroke programs, ALS clinics and rehabilitation teams to understand account-level patient needs and access barriers. Cross-functional execution: Coordinate with Market Access, Trade, Legal, Finance, Supply Chain, Sales, Medical Affairs, Patient Services and Commercial Operations to move opportunities from account plan to agreement to implementation. Performance management: Track account progress, contract status, pharmacy activation, product stocking, prescription pull-through, access barriers, revenue impact and executive relationship development. Commercial Agreements & Transactions Core agreement types Implementation responsibilities Group Purchasing Organization (GPOs) agreements Health-system purchase agreements Institutional pharmacy agreements Outpatient pharmacy participation agreements Contract pricing and discount arrangements Strategic commercial partnership agreements Contract pull-through plans Product stocking and fulfillment workflows 340B and contract pharmacy coordination Business reviews with account leadership Internal governance with Legal, Finance and Trade Target Customer Universe Institutional accounts Pharmacy and clinical programs Academic medical centers Integrated Delivery Networks (IDNs) 340B Covered Entities Disproportionate Share Hospitals (DSH) Rehabilitation hospitals VA and government-affiliated health systems Health-system outpatient pharmacies Hospital-owned specialty pharmacies Contract pharmacies and pharmacy networks Neuroscience institutes PM&R and spasticity programs MS, movement disorder, stroke and ALS centers Therapeutic and Portfolio Focus The role will support Rosemont's U.S. neurology strategy and current commercial focus on ONTRALFY® (tizanidine oral solution) for adult spasticity, while building relationships with institutions that manage patients across adjacent neurological disorders and medication-administration challenges. Priority patient populations Adjacent access opportunities Adults treated for spasticity Multiple sclerosis Stroke recovery Spinal cord injury Traumatic brain injury Cerebral palsy Parkinson's disease and movement disorders ALS and neurodegenerative disorders Dysphagia and swallowing disorders Enteral feeding tube patients Patients needing oral liquid alternatives Transitions from acute care to rehab to home

Qualifications

Bachelor's degree required; advanced degree in business, pharmacy, health administration or related field preferred. 10+ years of pharmaceutical, biotech, specialty pharmacy, market access, institutional account, health-system, national account or key account experience. Demonstrated ability to manage complex accounts and develop commercial relationships with IDNs, academic centers, outpatient pharmacies, 340B entities or institutional pharmacy programs. Experience supporting or negotiating purchase agreements, pricing arrangements, pharmacy participation agreements or institutional commercial contracts strongly preferred. Understanding of 340B, DSH hospitals, Medicare, Medicaid, commercial reimbursement, outpatient pharmacy, specialty pharmacy and trade/distribution channels preferred. Neurology, rehabilitation medicine, spasticity, movement disorders or complex chronic disease experience preferred. Strong business acumen, executive presence, negotiation skills, project management capability and cross-functional leadership. Success Measures Business outcomes Leadership outcomes Drive unit sales through substantial purchase orders Commercial agreements executed and implemented Outpatient pharmacies activated 340B and DSH opportunities developed Product access, stocking and fulfillment improved Executive account relationships established Account plans built and maintained Cross-functional execution delivered on time Institutional revenue and pull-through generated Scalable process created for future launches First-Year Objectives Build and prioritize a national target list of academic health systems, IDNs, 340B entities, outpatient pharmacy programs and neurology Centers of Excellence. Execute initial strategic commercial agreements with selected institutional accounts and establish implementation playbooks for stocking, fulfillment and pull-through. Create repeatable internal processes for Rosemont to support future neurology and specialty oral-liquid launches through institutional channels. Compliance Expectations All activities must be conducted in accordance with FDA-approved product labeling, applicable healthcare laws and regulations, Rosemont policies, pricing/contracting governance and promotional compliance standards.